Figure 3From: The antitumor immune response in HER-2 positive, metastatic breast cancer patientsThe mean values of the survival (S%) of MDA-MB-361 cells co-cultured for 48 h, with effectors PBMC, isolated from control healthy people and from the breast carcinoma patients, in nutrient medium with 10% of control, or autologous serum. E:T ratio was 5:1 (*P < 0.003).Back to article page